Concepedia

Gerhard Breipohl

GB

Statistics

Publications

28

Citations

2.8K

H-Index

20

Active since

1984

Affiliations

Klinikum Frankfurt Höchst(Current)

Behringwerke (Germany)

Gesundes Kinzigtal (Germany)

Gerhard Breipohl is an author at Klinikum Frankfurt Höchst specializing in pharmacology, pharmacy, and medicine.

Publications per year

1984–2001

28

Publications

28

Hoe 140 a new potent and long acting bradykinin‐antagonist:<i>in vivo</i>studies

Klaus Wirth, Franz J. Hock, Udo Albus et al. · British Journal of Pharmacology · 1991 · 835 citations · Full text

, , +5

Hoe 140 a new potent and long acting bradykinin‐antagonist:<i>in vitro</i>studies

Franz J. Hock, Klaus Wirth, Udo Albus et al. · British Journal of Pharmacology · 1991 · 614 citations · Full text

, , +5

New, long‐acting, potent bradykinin antagonists

F. Lembeck, Thomas Griesbacher, Martin Eckhardt et al. · British Journal of Pharmacology · 1991 · 214 citations · Full text

, , +10

Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist

Piero A. Martorana, Birgit Kettenbach, Gerhard Breipohl et al. · European Journal of Pharmacology · 1990 · 202 citations

, , +5

Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3, Thi5, D-Tic7, Oic8]bradykinin)

Nour-Eddine Rhaleb, N. Rouissi, Daniela Jukic et al. · European Journal of Pharmacology · 1992 · 124 citations

, , +7

1–5 of 28